Cambridge Investment Research Advisors’s FT Vest U.S. Equity Max Buffer ETF - July JULM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$240K Sell
6,936
-112
-2% -$3.84K ﹤0.01% 3649
2026
Q1
$236K Sell
7,048
-630
-8% -$21.2K ﹤0.01% 3520
2025
Q4
$258K Sell
7,678
-591
-7% -$19.7K ﹤0.01% 3352
2025
Q3
$275K Sell
8,269
-32,379
-80% -$1.06M ﹤0.01% 3185
2025
Q2
$1.32M Buy
40,648
+230
+0.6% +$7.28K ﹤0.01% 1733
2025
Q1
$1.26M Sell
40,418
-70
-0.2% -$2.21K ﹤0.01% 1674
2024
Q4
$1.27M Buy
40,488
+19
+0% +$595 ﹤0.01% 1676
2024
Q3
$1.26M Buy
+40,469
New +$1.24M ﹤0.01% 1693

Other funds holding JULM

Cambridge Investment Research Advisors's JULM Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its FT Vest U.S. Equity Max Buffer ETF - July (JULM) stake by 1.6% in Q2 2026, selling an estimated $3.84K and leaving 6,936 shares worth $240K. The position accounts for ﹤0.01% of the portfolio, ranked #3649.

Cambridge Investment Research Advisors first reported a position in JULM in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.32M in Q2 2025. 14 funds tracked by Wall St. Rank hold JULM as of Q2 2026.

  • Cambridge Investment Research Advisors held 6,936 shares of FT Vest U.S. Equity Max Buffer ETF - July worth $240K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 112 FT Vest U.S. Equity Max Buffer ETF - July shares in Q2 2026, an estimated $3.84K.
  • FT Vest U.S. Equity Max Buffer ETF - July made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3649 holding.
  • Cambridge Investment Research Advisors first reported a position in FT Vest U.S. Equity Max Buffer ETF - July in Q3 2024 and has held it in 8 quarters since.
  • Cambridge Investment Research Advisors's FT Vest U.S. Equity Max Buffer ETF - July position peaked at $1.32M in Q2 2025.
  • 14 funds tracked by Wall St. Rank held FT Vest U.S. Equity Max Buffer ETF - July as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.